Research and Markets: Patently Innovative: How Pharmaceutical Firms Use Emerging Patent Law to Extend Monopolies on Blockbuster Drugs
Research and Markets (http://www.researchandmarkets.com/research/jv65hc/patently) has announced the addition of Woodhead Publishing Ltd's new book "Patently innovative: How pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs" to their offering.
"Patently innovative" provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products.
Key Topics Covered:
- Drug approval, drug patenting, pharmaceutical linkage, and public health policy
- Empirical analysis of drug approval
- Empirical analysis of pharmaceutical innovation and drug approval-drug patenting linkage
- Empirical analysis of drug patenting in multiple high-value cohorts
- Implications of empirical data: Are pharmaceutical linkage regulations a success? Future directions: Testable hypotheses and evolution toward global pharmaceutical linkage.
For more information visit http://www.researchandmarkets.com/research/jv65hc/patently
Source: Woodhead Publishing Ltd